HomeClinical TopicsCardio-PulmonaryFDA approves Omontys for anemia in dialysis patients

FDA approves Omontys for anemia in dialysis patients

On March 29, the U.S. Food and Drug Administration (FDA) approved Omontys (peginesatide) to treat anemia in adult patients who had chronic kidney disease and are on dialysis. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content